STELAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Stelazine patents expire, and when can generic versions of Stelazine launch?
Stelazine is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in STELAZINE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stelazine
A generic version of STELAZINE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STELAZINE?
- What are the global sales for STELAZINE?
- What is Average Wholesale Price for STELAZINE?
Summary for STELAZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Patent Applications: | 172 |
| DailyMed Link: | STELAZINE at DailyMed |
US Patents and Regulatory Information for STELAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | CONCENTRATE;ORAL | 011552-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | INJECTABLE;INJECTION | 011552-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | STELAZINE | trifluoperazine hydrochloride | TABLET;ORAL | 011552-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
